⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 3 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT April 23, 2026

Ropivacain-HCl B. Braun 2 mg/ml Injektions-/ Infusionslösung 2 mg/ml (Injektions-/Infusionslösung)

📷 Wikipedia: Ropivacaine · Source
Ropivacain-HCl B. Braun 2 mg/ml Injektions-/ Infusionslösung 2 mg/ml (Injektions-/Infusionslösung)
📷 Wikipedia: Ropivacaine · Source
Ropivacaine hydrochloride B. Braun 2 mg/ml solution for injection/infusion is delayed in production. Affected packs: 20 vials per box, unavailable since 3 April 2026, restock expected 19 June 2026.
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 34 days ago.
📈 Timeline
3 days in total
May 18, 2026 May 21, 2026

What is this? Ropivacain-HCl B. Braun is a numbing medicine given as an injection or infusion. It is used to reduce pain during medical procedures.

What's happening? Some packs of this medicine are not available right now. The company expects them back in June.

Does this affect me? If you need this medicine now, ask your pharmacist or doctor for help.

What should I do? Talk to your pharmacist or doctor before changing your medicine. They can find a safe alternative for you.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
ROPIVACAIN HYDROCHLORID
Agency-published detail

ATC: N01BB09 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: B. Braun Melsungen AG, Carl-Braun-Straße 1, 34212 Melsungen, Federal Republic of Germany · Affected packs: 20 Stück Schachtel, Ampulle [Nicht verfügbar, since 2026-04-03, resupply 2026-06-19] · 20 Stück Schachtel, Ampulle [verfügbar]

First published
April 23, 2026
Last refreshed by us
6 days ago
Severity (as classified)
Low
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Ropivacain-HCl B. Braun 2 mg/ml Injektions-/ Infusionslösung 2 mg/ml (Injektions-/Infusionslösung). Ropivacaine hydrochloride B. Braun 2 mg/ml solution for injection/infusion is delayed in production. Affected packs: 20 vials per box, unavailable since 3 April 2026, restock expected 19 June 2026.
▸ When was this alert issued?
This alert was issued on April 23, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Low risk. A low risk means harm is unlikely under normal use. The alert is informational but still worth reading.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.